Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0000921895-15-001484

Options or other derivatives

  • Director bought 2,777,777 shares

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Eberwein Jeffrey E. Director 2015-05-26 Purchase · 5% Convertible Note due May 2017 +0 $5,000,000.00 $0 I
Eberwein Jeffrey E. Director 2015-05-26 Purchase · Warrant (Right to Buy) +2,777,777 2,777,777 I
Loading xslF345X03/form409482025_05282015.xml…